FDA 和 EMA 基于风险启动药品检查情形概述及对我国的启示

FDA 和 EMA 基于风险启动药品检查情形概述及对我国的启示

China Food Drug Administration ›› 2023, Vol. 0 ›› Issue (11) : 60-67.

PDF(1482 KB)

PDF(1482 KB)

China Food Drug Administration ›› 2023, Vol. 0 ›› Issue (11) : 60-67. DOI: 10.3969/j.issn.1673-5390.2023.11.007

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

Download Citations

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}

{{article.copyrightLicense_en}}

PDF(1482 KB)

Accesses

Citation

Detail

Sections

Recommended

/

〈

〉